Skip to content
Screener

NRX Pharmaceuticals, Inc. NRXP Q2 2026 earnings

Reported August 17, 2026 · Before market open

Revenue$1.1MMiss by $228.7K
EPS-$0.44Miss by $0.33
Revenue estimate$1.3M
EPS estimate-$0.11

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$1.3M
EPS estimate-$0.26

FAQ

When did NRX Pharmaceuticals, Inc. report Q2 2026 earnings?
NRX Pharmaceuticals, Inc. (NRXP) reported Q2 2026 earnings on August 17, 2026 before market open.
What were NRX Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
NRX Pharmaceuticals, Inc. reported revenue of $1.1M and eps of $-0.44 for Q2 2026.
Did NRX Pharmaceuticals, Inc. beat estimates in Q2 2026?
Revenue missed the consensus estimate of $1.3M by $228.7K. EPS missed the consensus estimate of $-0.11 by $0.33.
Where can I find NRX Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-028111) and the 10-Q periodic report (0001437749-26-028027) directly on SEC EDGAR. The filing index links above go to sec.gov.